Rchr
J-GLOBAL ID：201801005516301937   Update date: May. 03, 2024

Saito Hiroki

サイトウ ヒロキ | Saito Hiroki
Research field  (2)： Hygiene and public health (non-laboratory) ,  Infectious disease
Research keywords  (7)： COVID-19 ,  (re-)emerging infectious diseases ,  Sepsis ,  Global Health ,  Hand Hygiene ,  Infection Prevention and Control ,  Infectious Diseases
Research theme for competitive and other funds  (9)：
  • 2023 - 2027 Establishing Platform of Multi-Platform Trials for Pandemic Preparedness and Response
  • 2023 - 2026 Randomized controlled trial on the effectiveness of BioFire respiratory pathogen panel on clinical management of ventilator associated pneumonia
  • 2023 - 2026 Establishment of Bayesian platform trial on post cardiac arrest syndrome
  • 2023 - 2026 Cluster Randomized Trial and Impact Evaluation of Infection Prevention and Control in Uganda
  • 2022 - 2025 Informed consent in clinical trials with severe state COVID-19 patients: current practice and feasibility of electronic methods
Show all
Papers (55)：
  • Shigeru Koba, Kenichi Nakazono, Hiroki Saito, Naoaki Ichihara, Hiroyuki Kunishima, Shigeki Fujitani. The protocol and current situation of antibiotic and macrolide domains of an international adaptive platform trial “REMAP-CAP”. The Japanese Journal of Antibiotics. 2024. 77. 1. 100-106
  • Christopher J. Yarnell, Hiroki Saito, John C. Marshall. Understanding Heterogeneity in Acute Care Trials: Resource Availability Impacts Outcomes. American Journal of Respiratory and Critical Care Medicine. 2024. 209. 5. 469-471
  • Ermira Tartari, Fernando Bellissimo-Rodrigues, Daniela Pires, Carolina Fankhauser, Nasim Lotfinejad, Hiroki Saito, Miranda Suchomel, Axel Kramer, Benedetta Allegranzi, John Boyce, et al. Updates and future directions regarding hand hygiene in the healthcare setting: insights from the 3rd ICPIC alcohol-based handrub (ABHR) task force. Antimicrobial Resistance and Infection Control. 2024. 13. 1
  • The REMAP-CAP Investigators. Simvastatin in Critically Ill Patients with Covid-19. New England Journal of Medicine. 2023. 389. 25. 2341-2354
  • The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators. Intravenous Vitamin C for Patients Hospitalized With COVID-19. JAMA. 2023. 330. 18. 1745-1745
ｍore...
MISC (2)：
  • 吉田 稔, 吉田 徹, 本橋 隆子, 斉藤 浩輝, 桝井 良裕, 藤谷 茂樹, 北村 伸哉, 立石 順久, 田上 隆, 武田 宗和. Non-shockable院外心停止における高体温回避の重要性 SOS-KANTO 2017 study. 日本救急医学会雑誌. 2023. 34. 12. 706-706
  • 跡部 かおり, 斎藤 浩輝, 藤谷 茂樹. 【COVID-19(ICUにおけるパンデミック対策)】新興再興感染症 敗血症診療ガイドラインはどこまで重症の新興再興感染症に対応できるか?. Intensivist. 2021. 13. 3. 465-470
Professional career (3)：
  • MD (Niigata University)
  • MPH (Boston University School of Public Health)
  • PhD (University of Geneva)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM